However, many tumors downregulate HLA genes or genes associated with the antigen presentation process, like TAP1, TAP2, IFNγR, or show loss of HLA heterozygosity in tumor cells, affecting the antigen-presenting machinery [384,392]. The gene discussed is IFNGR1; the disease is neoplasm.